Maryland 2025 Regular Session

Maryland Senate Bill SB94

Introduced
1/8/24  
Introduced
1/8/25  
Refer
1/8/24  
Refer
1/8/25  
Report Pass
2/17/25  
Engrossed
2/20/25  
Refer
2/21/25  
Report Pass
3/31/25  
Report Pass
3/28/25  
Enrolled
3/31/25  
Chaptered
5/20/25  

Caption

Maryland Medical Assistance Program - Maternal Health Self-Measured Blood Pressure Monitoring

Impact

The implementation of SB94 is expected to enhance maternal health by empowering eligible recipients to monitor their blood pressure at home, thereby facilitating early detection of potential health issues. With the measure, Maryland aims to lower healthcare costs associated with hospital admissions and complications stemming from unmanaged blood pressure levels. The bill also outlines a requirement for the MMAP to develop an education campaign that informs recipients and healthcare providers about the benefits of home blood pressure monitoring and offers support for device setup and troubleshooting.

Summary

Senate Bill 94, known as the Maryland Medical Assistance Program – Maternal Health Self-Measured Blood Pressure Monitoring Act, proposes to expand the Maryland Medical Assistance Program's (MMAP) coverage to include self-measured blood pressure monitoring for eligible program recipients. This bill specifically focuses on pregnant individuals and those diagnosed with chronic kidney disease, diabetes, heart disease, or cardiometabolic diseases. Beginning January 1, 2026, the bill intends to improve health outcomes by offering validated home blood pressure monitors and reimbursement for healthcare provider time associated with patient training and data monitoring.

Sentiment

Overall sentiment surrounding SB94 appears to be positive, particularly among maternal health advocates and healthcare providers who believe that empowering patients with self-monitoring tools can lead to better health outcomes. Supporters argue that the bill represents a proactive approach to healthcare, focusing on prevention and patient engagement. However, concerns were raised regarding the adequacy of resources and training for both patients and providers to effectively implement the monitoring system.

Contention

Notable points of contention regarding SB94 include discussions on who will be eligible for the self-measured blood pressure monitoring program and how the state plans to manage and fund the associated costs of increased coverage. Critics express concerns about the sustainability of extending such services amidst budget constraints while advocates highlight the potential long-term cost savings that could arise from reducing the prevalence of serious hypertension-related health issues. The requirement for an annual reporting mechanism should provide additional transparency regarding the program's impact and effectiveness as it moves forward.

Companion Bills

MD HB553

Crossfiled Maryland Medical Assistance Program - Maternal Health Self-Measured Blood Pressure Monitoring

Previously Filed As

MD HB1376

Maryland Medical Assistance Program, Maryland Children's Health Program, and Health Insurance - Special Pediatric Hospitals

MD SB460

Maryland Medical Assistance Program – Gender–Affirming Treatment (Trans Health Equity Act)

MD HB283

Maryland Medical Assistance Program - Gender-Affirming Treatment (Trans Health Equity Act)

MD SB627

Maryland Medical Assistance Program - Emergency Dialysis Services

MD SB805

Maryland Medical Assistance Program and Health Insurance – Required Coverage for Biomarker Testing

MD HB1217

Maryland Medical Assistance Program and Health Insurance - Required Coverage for Biomarker Testing

MD SB441

Maryland Medical Assistance Program - Prescription Digital Therapeutics

MD HB813

Maryland Medical Assistance Program – Prescription Digital Therapeutics

MD SB75

Insurance and Maryland Medical Assistance Program – Treatment of Alopecia Areata – Coverage Requirements

MD HB111

Maryland Medical Assistance Program, Maryland Children's Health Program, and Workgroup on Low-Income Utility Assistance

Similar Bills

MD HB950

Maryland Native Plants Program

MD SB836

Maryland Native Plants Program

MD HB161

Northeast Maryland Waste Disposal Authority - Evaluation, Termination of Bond Authority, and Assumption of Functions, Employees, and Contracts (Northeast Maryland Waste Disposal Authority Sunset Act)

MD HB1124

Maryland Department of Health - 2-1-1 Maryland, Maryland Think, and Maryland OneStop - Study

DE HCR156

Urging The State Of Maryland To Allow The Sale Of Certified Delaware Sod In Maryland.

MD SB14

Sustainable Maryland Program and Fund - Establishment

MD HB530

Maryland Trails Advisory Committee and the Maryland Office of Trails - Establishment (Great Maryland Trails Act)

MD SB645

Maryland Trails Advisory Committee and the Maryland Office of Trails - Establishment (Great Maryland Trails Act)